No image published for this recall

No image published for this recall

Ortho vision and vision max analyzer

Official notice

14 Jul 2023

Last checked

14 Jul 2023

Medium riskHealth Canada

An official Health Canada notice concerns Ortho vision and vision max analyzer. Ortho Clinical Diagnostics (QuidelOrtho™) identified a trend regarding false positive results for specific tests (listed below) processed after Ortho Sera Anti-Jkb Tests, on the ID-MTS™ buffered gel cards when tested on the Ortho Vision Analyzer. It is important to note that this issue is intermittent because several factors must interact across a series of events for a false positive test result due to ortho sera antijkb carryover to occur. • One of the five tests listed below must be performed on the Ortho Vision/ Vision Max Analyzer in conjunction with or after the Ortho Sera Anti-Jkb testing, and • Ortho Sera Anti-Jkb must be pipetted one or two steps before a sample or reagent in one of the tests listed below, and • The red blood cells in the test pipetted after Ortho Sera Anti-Jkb must express the Jkb antigen. The likelihood of occurrence is higher with red cells with higher antigen expression, and • The intermittent occurrence of Ortho Sera Anti-Jkb carryover is also dependent on several factors specific to pipetting operations on the Ortho Vision/Vision Max Analyzer such as the volume of reagents and samples pipetted, and the amount of time they are retained in the probe between aspiration and dispense which are determined by the analyzer processing steps. Recall start date: June 28, 2023 Published 2023-07-14.

What to do now

Review notice & retain for lab, return reply form, continued use must only occur using supplied directions.

Recall number

73953

Official notice

2023-07-14

The hazard

Ortho Clinical Diagnostics (QuidelOrtho™) identified a trend regarding false positive results for specific tests (listed below) processed after Ortho Sera Anti-Jkb Tests, on the ID-MTS™ buffered gel cards when tested on the Ortho Vision Analyzer. It is important to note that this issue is intermittent because several factors must interact across a series of events for a false positive test result due to ortho sera antijkb carryover to occur. • One of the five tests listed below must be performed on the Ortho Vision/ Vision Max Analyzer in conjunction with or after the Ortho Sera Anti-Jkb testing, and • Ortho Sera Anti-Jkb must be pipetted one or two steps before a sample or reagent in one of the tests listed below, and • The red blood cells in the test pipetted after Ortho Sera Anti-Jkb must express the Jkb antigen. The likelihood of occurrence is higher with red cells with higher antigen expression, and • The intermittent occurrence of Ortho Sera Anti-Jkb carryover is also dependent on several factors specific to pipetting operations on the Ortho Vision/Vision Max Analyzer such as the volume of reagents and samples pipetted, and the amount of time they are retained in the probe between aspiration and dispense which are determined by the analyzer processing steps. Recall start date: June 28, 2023

How to check if you're affected

Compare the product name and identifiers below with the item you own. Follow the official notice if they match.

Recall Numbers

73953

Checked manually this time?

The app alerts you when a new official recall is published — no searching, no checking back.

Turn on recall alerts

Affected products

Product 1

Affected products - Ortho Vision Analyzer, Lot or serial number - Software 5.14.5 and below, Model or catalog number - 6904577

Product 2

Affected products - Ortho Vision Max Analyzer, Lot or serial number - Software 5.14.5 and below, Model or catalog number - 6904576

Risk / hazard

Ortho Clinical Diagnostics (QuidelOrtho™) identified a trend regarding false positive results for specific tests (listed below) processed after Ortho Sera Anti-Jkb Tests, on the ID-MTS™ buffered gel cards when tested on the Ortho Vision Analyzer. It is important to note that this issue is intermittent because several factors must interact across a series of events for a false positive test result due to ortho sera antijkb carryover to occur. • One of the five tests listed below must be performed on the Ortho Vision/ Vision Max Analyzer in conjunction with or after the Ortho Sera Anti-Jkb testing, and • Ortho Sera Anti-Jkb must be pipetted one or two steps before a sample or reagent in one of the tests listed below, and • The red blood cells in the test pipetted after Ortho Sera Anti-Jkb must express the Jkb antigen. The likelihood of occurrence is higher with red cells with higher antigen expression, and • The intermittent occurrence of Ortho Sera Anti-Jkb carryover is also dependent on several factors specific to pipetting operations on the Ortho Vision/Vision Max Analyzer such as the volume of reagents and samples pipetted, and the amount of time they are retained in the probe between aspiration and dispense which are determined by the analyzer processing steps. Recall start date: June 28, 2023

Where it was sold

The source does not list specific retailers. See the official notice for where affected products were sold.

Location 1

CA · Canada

Affected area 1

CA · Canada

Company & contacts

Manufacturer

Not provided

Phone

Not provided

Brand: Ortho-clinical Diagnostics, Ortho Vision And Vision Max Analyzer.

Source & status

Source

Health Canada

Tier

official

Category

HOME

Classification

Type II

App estimate

medium

Recall details

Recall number

73953

Classification

Type II

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Related recalls

CA
No image published for this recall

Vitros chemistry product system-ca slides (calcium)

Medium riskHealth Canada24 Jul 2025
CA
No image published for this recall

Vitros® 4600, 5600 and 7600 systems

Medium riskHealth Canada5 Jun 2025
CA
No image published for this recall

Ortho vision analyzer

Medium riskHealth Canada9 May 2025
CA
No image published for this recall

Vitros chemistry products system - crp slides (c-reactive protein)

Medium riskHealth Canada9 May 2025
CA
No image published for this recall

Vitros® chemistry products system - lac slides (lactate)

Medium riskHealth Canada14 Aug 2025
CA
No image published for this recall

Ortho optix reader

Medium riskHealth Canada13 Feb 2025
CA
No image published for this recall

Vitros® 5600, 3600 and xt systems

Medium riskHealth Canada9 Jan 2025
CA
No image published for this recall

Vitros® chemistry products system - dgxn slides (digoxin)

Medium riskHealth Canada19 Dec 2024
CA
No image published for this recall

Ortho vision analyzer

Medium riskHealth Canada22 Nov 2024
CA
No image published for this recall

Vitros chemistry products system - crp slides (c-reactive protein)

Medium riskHealth Canada6 Nov 2024
CA
No image published for this recall

Vitros® xt chemistry product alb-tp slides

Medium riskHealth Canada25 Jul 2024
CA
No image published for this recall

Vitros chemistry products fs diluent

Medium riskHealth Canada20 Jun 2024

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 14 Jul 2023. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.